• About Us
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Technology
    • Introduction
    • Anti-CD3 oral immunotherapy
    • VaxiSome
    • Group-common Pneumococcal Vaccine
    • Alzheimer's Disease
    • Publications
  • Pipeline
    • Overview
    • Inflammatory and auto-immune diseases
    • Influenza
    • Hepatitis B
    • Pneumococcal
    • Alzheimer’s Disease
    • Pandemic Influenza
    • Anthrax
  • Partnering
    • Partnering
  • Investors
    • Releases
    • Events
    • Stock Info
    • Financial Reports (Hebrew)
    • Press Clippings
  • Overview
  • Inflammatory and auto-immune diseases
  • Influenza
  • Hepatitis B
  • Pneumococcal
  • Alzheimer’s Disease
  • Pandemic Influenza
  • Anthrax
  • Pipeline
  • Overview

Overview

NasVax has three products in clinical development and five in preclinical development

Influenza Intramuscular Influenza Intranasal Hepatitis B Alzheimer's Disease Anthrax Pandemic Influenza

  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Site Map
Site by mantis